375 related articles for article (PubMed ID: 2882835)
41. Activation of macrophage tumoricidal activity by photodynamic treatment in vitro--indirect activation of macrophages by photodynamically killed tumor cells.
Reiter I; Schwamberger G; Krammer B
J Photochem Photobiol B; 1999 Jun; 50(2-3):99-107. PubMed ID: 10515075
[TBL] [Abstract][Full Text] [Related]
42. Macrophage tumor necrosis factor-alpha release is induced by contact with some tumors.
Hasday JD; Shah EM; Lieberman AP
J Immunol; 1990 Jul; 145(1):371-9. PubMed ID: 2358679
[TBL] [Abstract][Full Text] [Related]
43. Macrophage activation to kill Leishmania major: activation of macrophages for intracellular destruction of amastigotes can be induced by both recombinant interferon-gamma and non-interferon lymphokines.
Nacy CA; Fortier AH; Meltzer MS; Buchmeier NA; Schreiber RD
J Immunol; 1985 Nov; 135(5):3505-11. PubMed ID: 3930606
[TBL] [Abstract][Full Text] [Related]
44. Discrimination between macrophage-and NK-type tumoricidal activities via anti-asialo GM1 antibody.
Keller R; Bächi T; Okumura K
Exp Cell Biol; 1983; 51(3):158-64. PubMed ID: 6852344
[TBL] [Abstract][Full Text] [Related]
45. Modulation of macrophage function by gamma-irradiation. Acquisition of the primed cell intermediate stage of the macrophage tumoricidal activation pathway.
Lambert LE; Paulnock DM
J Immunol; 1987 Oct; 139(8):2834-41. PubMed ID: 3116096
[TBL] [Abstract][Full Text] [Related]
46. Enhancement of human monocyte tumoricidal activity by recombinant M-CSF.
Sampson-Johannes A; Carlino JA
J Immunol; 1988 Nov; 141(10):3680-6. PubMed ID: 3053901
[TBL] [Abstract][Full Text] [Related]
47. Induction, maintenance, and reinduction of tumoricidal activity in bone marrow-derived mononuclear phagocytes by Corynebacterium parvum. Evidence for the involvement of a T cell- and interferon-gamma-independent pathway of macrophage activation.
Keller R; Keist R; Van der Meide PH; Groscurth P; Aguet M; Leist TP
J Immunol; 1987 Apr; 138(7):2366-71. PubMed ID: 3104463
[TBL] [Abstract][Full Text] [Related]
48. Influences of interleukins 2 and 4 on tumor necrosis factor production by murine mononuclear phagocytes.
McBride WH; Economou JS; Nayersina R; Comora S; Essner R
Cancer Res; 1990 May; 50(10):2949-52. PubMed ID: 2334896
[TBL] [Abstract][Full Text] [Related]
49. Regulation of activated macrophage antimicrobial activities. Cooperation of lymphokines for induction of resistance to infection.
Davis CE; Belosevic M; Meltzer MS; Nacy CA
J Immunol; 1988 Jul; 141(2):627-35. PubMed ID: 3133412
[TBL] [Abstract][Full Text] [Related]
50. Study of the dependence of human monocytes and macrophages antitumoral properties upon TNF-alpha expression or release.
Dumont S; Mabondzo A; Hartmann D; Gilgenkrantz JL; Kessler R; Poindron P; Bartholeyns J
Anticancer Res; 1990; 10(4):949-54. PubMed ID: 2116753
[TBL] [Abstract][Full Text] [Related]
51. Involvement of tumor necrosis factor in cytotoxicity mediated by human monocytes.
Nissen-Meyer J; Hofsli E; Espevik T; Austgulen R
Nat Immun Cell Growth Regul; 1988; 7(5-6):266-79. PubMed ID: 3146697
[TBL] [Abstract][Full Text] [Related]
52. In vivo and in vitro activation of alveolar macrophages by recombinant interferon-gamma.
Black CM; Catterall JR; Remington JS
J Immunol; 1987 Jan; 138(2):491-5. PubMed ID: 3098846
[TBL] [Abstract][Full Text] [Related]
53. Mechanistic differences between migration inhibitory factor (MIF) and IFN-gamma for macrophage activation. MIF and IFN-gamma synergize with lipid A to mediate migration inhibition but only IFN-gamma induces production of TNF-alpha and nitric oxide.
Herriott MJ; Jiang H; Stewart CA; Fast DJ; Leu RW
J Immunol; 1993 May; 150(10):4524-31. PubMed ID: 7683323
[TBL] [Abstract][Full Text] [Related]
54. The glycosyl-inositol-phosphate and dimyristoylglycerol moieties of the glycosylphosphatidylinositol anchor of the trypanosome variant-specific surface glycoprotein are distinct macrophage-activating factors.
Magez S; Stijlemans B; Radwanska M; Pays E; Ferguson MA; De Baetselier P
J Immunol; 1998 Feb; 160(4):1949-56. PubMed ID: 9469458
[TBL] [Abstract][Full Text] [Related]
55. Bryostatin-1 and IFN-gamma synergize for the expression of the inducible nitric oxide synthase gene and for nitric oxide production in murine macrophages.
Taylor LS; Cox GW; Melillo G; Bosco MC; Espinoza-Delgado I
Cancer Res; 1997 Jun; 57(12):2468-73. PubMed ID: 9192827
[TBL] [Abstract][Full Text] [Related]
56. Expression of a 120,000 dalton protein during tumoricidal activation in murine peritoneal macrophages.
Johnston PA; Somers SD; Hamilton TA
J Immunol; 1987 Apr; 138(8):2739-44. PubMed ID: 3104474
[TBL] [Abstract][Full Text] [Related]
57. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
Liepins A; Nowicky JW
Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
[TBL] [Abstract][Full Text] [Related]
58. In vitro induction of tumoricidal and suppressor macrophages by lymphokines: possible feedback regulation.
Taramelli D; Holden HT; Varesio L
J Immunol; 1981 Jun; 126(6):2123-8. PubMed ID: 6453155
[TBL] [Abstract][Full Text] [Related]
59. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes.
Fidler IJ; Fogler WE; Kleinerman ES; Saiki I
J Immunol; 1985 Dec; 135(6):4289-96. PubMed ID: 3934281
[TBL] [Abstract][Full Text] [Related]
60. [Mechanisms of macrophage activation and macrophage-mediated tumoricidal activity].
Kiyotaki C
Gan To Kagaku Ryoho; 1989 Oct; 16(10):3386-91. PubMed ID: 2508564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
